Belongs to

• Solid Tumor Oncology Division

Types of Work

["2022"]

[[["Journal Articles",1104],["Meeting Abstracts",902],["Reviews",55],["Book Sections",46],["Editorials",36],["Guidelines",22],["Correspondences",9],["Miscellaneous",3],["Research Letters",2],["Book Wholes",1]]]

[2180]

Popular keywords

• adult
• aged
• article
• clinical trial
• controlled study
• female
• human
• humans
• major clinical study
• middle aged

Recent Works

1. A first-in-human phase 1 study Of LY4170156, an antibody-drug conjugate targeting folate receptor α (FRα)-expressing advanced solid tumors (trial in progress)

   Meeting Abstract

   Ray-Coquard, I. L.; O'Malley, D. M.; Oaknin, A.; Pothuri, B.; Lorusso, D.; Eskander, R. N.; Westin, S. N.; Lakhani, N.; McKean, W. B.; Koyama, T.; more...
   International Journal of Gynecological Cancer (2025)

   Fulltext@MSK | Save
2. An open-label, multicentre, phase 2 study of trastuzumab deruxtecan in patients with HER2-expressing solid tumours: DESTINY-PanTumor02 Part 2

   Meeting Abstract

   Oaknin, A.; Lee, J. Y.; Makker, V.; Oh, D. Y.; Anoka, C.; Jung, L.; Puvvada, S.; Simões, J.; Meric-Bernstam, F.
   International Journal of Gynecological Cancer (2025)

   Fulltext@MSK | Save
3. Multimodal AI modeling of clinical panel-based sequencing for HRD detection in ovarian cancer

   Meeting Abstract

   Alsaafin, A.; Pollard, T.; Aukerman, A. T.; Boehm, K.; Pasha, A.; Moore, D.; Rusk, N.; Begum, A.; Sullivan, M. W.; Graves, S.; more...
   Clinical Cancer Research (2025)

   Fulltext@MSK | Save